Page last updated: 2024-08-16

ribavirin and Depression

ribavirin has been researched along with Depression in 85 studies

Research

Studies (85)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's34 (40.00)29.6817
2010's48 (56.47)24.3611
2020's3 (3.53)2.80

Authors

AuthorsStudies
Bebek-Ivankovic, H; Bevanda, M; Grgic, S; Nikolic, J; Soldo-Coric, L; Susak, B1
Bugajska, J; Inglot, M; Janocha-Litwin, J; Malyszczak, K; Marciniak, D; Pawlak, D; Pawlowski, T; Zalewska, M1
Baumert, TF; Berg, T; Brants, L; Buggisch, P; Discher, T; Friebe, A; Fromm, G; Kemper, J; Lieb, K; Link, R; Ockenga, J; Reimer, J; Rentrop, M; Sarkar, R; Sarkar, S; Schaefer, M; Schläpfer, T; Spengler, U; Weidenbach, H; Zeuzem, S1
Baeg, JY; Cho, J; Chung, JW; Jang, ES; Jeong, SH; Jung, EU; Kim, IH; Kim, JW; Kim, YS; Seo, SY1
Barbosa, MED; Carrilho, FJ; de Campos Mazo, DF; de Oliveira, CPMS; Farias, AQ; Pessoa, MG; Zaninotto, AL1
Bräu, N; Dieterich, DT; Gorman, JM; Marcus, SM; Prieto, S; Stivala, A; Weiss, JJ1
Gruenhage, F; Hahn, D; Kaiser, R; Lammert, F; Meyer, MR; Stokes, CS1
Gross, R; Guyatt, G; Lev-Ran, S; Saad, A; Yekutieli, D1
Frydecka, D; Hadryś, T; Inglot, M; Małyszczak, K; Pawłowski, T1
Ahmed, GK; Darwish, AM; Hassaan, SH; Hassany, SM; Khalifa, H; Moustafa, EF; Ramadan, HKA1
Bourlière, M; Bronowicki, JP; Chimienti, F; Cleophax, S; Doffoel, M; Lang, JP; Pujol, JF; Salvetat, N; Schwan, R; Van der Laan, S; Vire, B; Weissmann, D1
Hopwood, M1
Capuron, L; de la Torre, R; Giménez, D; Gratacòs, M; Langohr, K; Martín-Santos, R; Moreno-España, J; Navinés, R; Solà, R; Udina, M1
Amano, K; Arinaga, T; Fujimoto, Y; Ide, T; Ishii, K; Kuhara, K; Kumashiro, R; Kuwahara, R; Miyajima, I; Morita, Y; Murashima, S; Ogata, K; Sakai, K; Sata, M; Shirachi, M; Uchimura, N1
Anderson, RT; Baran, RW; Dietz, B; Erickson, P; Gooch, K; Revicki, DA1
Bride, BE; Nackerud, LG; Sims, OT; Whalen, CC1
Hou, XJ; Wang, J; Xu, JH; Yu, YY1
Bonner, JE; Esserman, DA; Evon, DM; Golin, CE1
Bayliss, MS; Crosby, RD; L'Italien, G; Mathias, S; Sapra, S1
Baranyi, A; Kapfhammer, HP; Meinitzer, A; Putz-Bankuti, C; Rothenhäusler, HB; Stauber, R1
Blunn, A; Chitturi, S; Farrell, G; Kaye, G; Rodrigo, K; Rodriguez-Morales, I; Shadbolt, B; Teoh, N; To, C; Wu, JY1
Avasthi, A; Chawla, YK; Grover, S; Mahajan, S1
Bezemer, G; de Knegt, RJ; Hansen, BE; Hotho, DM; Janssen, HL; Van Gool, AR; Veldt, BJ1
Barakat, F; Cattie, JE; Cherner, M; Franklin, D; Grant, I; Hassanein, T; Heaton, RK; Letendre, SL; Perry, W; Umlauf, A; Woods, SP1
Kawano, A; Miyagi, Y; Nomura, H; Tanimoto, H; Yamashita, N1
Arbuckle, R; Beumont, M; Brohan, E; Fu, M; Gilles, L; Jessner, W; Panter, C; Scott, J1
Ferenci, P; Ferenci-Förster, D; Hagmann, M; Kienbacher, C; Miehsler, W; Moser, G; Reichhold, D; Scherzer, TM; Staufer, K1
Joshita, S; Tanaka, E1
Eccles, J; Fialho, R; File, A; Haq, I; Keller, M; Pereira, M; Rolt, M; Tibble, J; Whale, R1
Felger, JC; Haroon, E; Miller, AH; Raison, CL; Woolwine, BJ1
Artigas, F; Egmond, E; Gimenez, D; Gómez-Gil, E; Grande, I; Gratacós, M; Kapczinski, F; Langohr, K; Martín-Santos, R; Navinés, R; Oriolo, G; Solà, R; Udina, M; Valdés, M; Vieta, E1
Bertino, G; Caraci, F; Chisari, G; Drago, F; Greco, C; Malaguarnera, G; Malaguarnera, M; Motta, M; Nunnari, G; Vacante, M; Vecchio, M1
Chang, JJ; Chen, CK; Chen, LW; Chen, SW; Chien, RN; Lee, TS; Liu, CJ; Wang, LJ; Yen, CL1
Frydecka, D; Małyszczak, K; Pawlak, D; Pawłowski, T1
Borisov, AS; Massung, B; Miller, AH; Raison, CL; Vogt, G; Woolwine, BJ1
Hopwood, M; Treloar, C1
Back-Madruga, C; Bieliauskas, LA; Fontana, RJ; Kronfol, Z; Lindsay, KL; Lok, AS; Padmanabhan, L; Stoddard, AM1
Ferenci, P1
Conti, CM; Dalessandro, M; Falasca, K; Mancino, P; Manzoli, L; Pizzigallo, E; Ucciferri, C; Vecchiet, J1
Alvarez-Uria, G; Day, JN; Nasir, AJ; Russell, SK; Vilar, FJ1
Poll, R1
Belle, SH; Evon, DM; Fontana, RJ; Fried, MW; Ramcharran, D; Terrault, NA1
Keicher, C; Kraus, MR; Rieger, P; Schäfer, A; Scheurlen, M; Seufert, J; Weissbrich, B1
Dantzer, R; Kelley, KW; Lawson, MA; Miller, AH; Raison, CL; Saito, K; Spivey, JR; Vogt, G; Woolwine, BJ1
Ackermann, G; Waizmann, M1
Kenis, G; Koek, GH; Prickaerts, J; Robaeys, G; Steinbusch, HW; van Os, J; Wichers, M1
Brown, GR; Cubillas, R; Grumbeck, C; Hale, T; Phillips, FH; Prebis, M1
Abate, G; Bertino, G; Boemi, P; Calvagno, GS; Di Pino, A; Giancarlo, C; Ignaccolo, L; Judica, A; Maiorca, D; Mastrosimone, G; Mauceri, B; Misseri, M; Neri, S; Palermo, F; Petralia, A; Rizzotto, A; Vadalà, G1
Bernardinello, E; Bertazzo, A; Cavalletto, L; Chemello, L; Comai, S; Costa, CV; Ragazzi, E1
Alagbe, O; Felger, JC; Hu, F; Miller, AH; Pace, TW; Raison, CL; Woolwine, BJ1
Carral Martínez, M; García-Toro, M; Gili Planas, M; Jimeno Beltrán, T; Pradas Guerrero, C; Roca Bennasar, M; Román Ruiz del Moral, Y; Vilella Martorell, A1
de Oliveira, IR; Galvão-de Almeida, A; Guindalini, C; Koenen, KC; Lyra, AC; Miranda-Scippa, A; Paraná, R; Parise, CL; Quarantini, LC; Sampaio, AS1
Carrieri, MP; Dabis, F; Fugon, L; Lacombe, K; Roux, P; Salmon-Céron, D; Sogni, P; Spire, B; Winnock, M1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Imai, N; Kawamura, Y; Kobayashi, M; Kumada, H; Matsumoto, N; Saito, S; Seko, Y; Sezaki, H; Suzuki, F; Suzuki, Y1
Lou, M; Park, SH; Wackernah, RC1
Alavi, M; Day, C; Dore, GJ; Grebely, J; Haber, PS; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Van Beek, I; Yeung, B1
Cole, SW; Doho, GH; Felger, JC; Hu, F; Miller, AH; Pace, TW; Raison, CL; Woolwine, BJ1
Andersen, JW; Butt, AA; Chung, RT; Hua, L; Kemmer, N; Sherman, KE1
Durández Lazaro, R; Fábregas Puigtió, S; Planas Vilà, R; Vega Palomares, R1
Folwaczny, C; Grunze, H; Heldwein, W; Koenig, A; Loeschke, K; Lorenz, R; Martin, G; Schaefer, M; Schindlbeck, N; Schmidt, F; Soyka, M1
Hadziyannis, S; Koskinas, J; Manesis, E; Merkouraki, P1
Ball, L; Berggren, R; Dieterich, DT; Felizarta, F; Goodman, R; Khalili, M; Slim, J; Smith, C; Sulkowski, MS1
Bagheri, H; Barange, K; Fouladi, A; Lapeyre-Mestre, M; Montastruc, JL; Payen, JL; Vinel, JP1
Biglia, A; Blanch, J; Blanco, JL; de Pablo, J; García, F; Gatell, JM; Laguno, M; Larrousse, M; León, A; Lonca, M; Mallolas, J; Martinez, E; Miró, JM; Murillas, J1
Al-Taie, O; Kraus, MR; Schäfer, A; Scheurlen, M1
Barry, K; Cleare, AJ; Hotopf, M; Landau, S; Maddock, C; Maulayah, P; Norris, S; Pariante, CM1
Apale, P; Avolio, A; Bellia, V; Bordoni, T; Parravicini, P; Pioltelli, P; Pozzi, M; Redaelli, A; Roffi, L; Santamaria, G; Scalori, A1
Czarnecki, M; Gładysz, A; Inglot, M; Jańczak, G; Małyszczak, K; Pawłowski, T; Rymer, W1
Antinori, A; Carioti, J; Caroleo, B; Guadagnino, V; Trotta, MP1
Gholam, PM; Rich, JD; Schwartzapfel, B; Taylor, LE1
Crone, C; Dan, AA; Farmer, DW; Martin, LM; Ong, JP; Robbins, SC; Wise, T; Younossi, ZM1
Chang, WW; Chen, CL; Cheng, JT; Fan, CW; Lin, YS; Lo, HY; Tsao, CW; Wu, SR1
De Heusden, N; Fischer, K; Mauser-Bunschoten, EP; Posthouwer, D1
Bardadin, K; Berak, H; Horban, A; Paprocka, H; Stańczak, JJ; Wasilewski, M1
Kallman, J; Kincaid, J; Younossi, Z1
Bonkovsky, H; Faris-Young, S; Huntley, B; Lyons, MF; Reddy, KR; Ryan, M; Santoro, J; Sjogren, MH; Sjogren, R; Smith, C1
Fucci, JC; Gleason, OC; Philipsen, MA; Yates, WR1
Kraus, MR; Schäfer, A; Scheurlen, M; Schöttker, K; Weissbrich, B1
Berg, T; Friebe, A; Gutsche, J; Halangk, J; Heinz, A; Hinzpeter, A; Janssen, G; Kluschke, M; Mohmand, A; Pich, M; Sarkar, R; Schaefer, M; Schwaiger, M; Weich, V; Ziemer, M1
Ardevol, M; Castellví, P; Díez-Quevedo, C; Galeras, JA; García, F; Martín-Santos, R; Masnou, H; Miquel, M; Navinés, R; Planas, R; Solà, R; Soler, A1
Esposito, S; Hamzeh, FM; Rustgi, VK; Shiffman, ML1
Capuron, L; Majer, M; Miller, AH; Pagnoni, G; Raison, CL; Welberg, LA1
Annable, L; Benkelfat, C; Brouillette, MJ; Cooper, C; Klein, MB; Kraus, D; Sheehan, NL; Singer, J; Weston, F1
Aitchison, KJ; Alexander, N; Binder, EB; Bull, SJ; Cassidy, E; Cleare, AJ; Cubells, JF; Hotopf, M; Huezo-Diaz, P; Maddock, C; Miller, AH; Miyazaki, C; Norris, S; Pariante, CM; Ranjith, G1
Fontana, RJ1

Reviews

6 review(s) available for ribavirin and Depression

ArticleYear
Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Antidepressive Agents; Antiviral Agents; Citalopram; Depression; Double-Blind Method; Hepatitis C, Chronic; Humans; Interferon-alpha; Paroxetine; Polyethylene Glycols; Randomized Controlled Trials as Topic; Ribavirin; Treatment Outcome

2013
Peginterferon and ribavirin in HCV: improvement of sustained viral response.
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6

    Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Medication Adherence; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome

2008
The role of the community nurse in hepatitis C diagnosis and treatment.
    British journal of community nursing, 2009, Volume: 14, Issue:7

    Topics: Antiviral Agents; Community Health Nursing; Depression; Drug Monitoring; Fatigue; Hepatitis C; Humans; Infection Control; Interferon alpha-2; Interferon-alpha; Neutropenia; Nurse's Role; Nursing Assessment; Patient Education as Topic; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Social Support; United Kingdom

2009
[Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Gastroenterologia y hepatologia, 2002, Volume: 25, Issue:8

    Topics: Acute Disease; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Depression; Drug Evaluation; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Hyperbilirubinemia; Interferon-alpha; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Spain; Thyroiditis; Viral Load; Viremia

2002
The effects of HCV infection and management on health-related quality of life.
    Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:3

    Topics: Antiviral Agents; Chronic Disease; Depression; Fatigue; Health Status; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin

2007
Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C.
    Digestive diseases (Basel, Switzerland), 2000, Volume: 18, Issue:3

    Topics: Antiviral Agents; Anxiety; Chronic Disease; Cognition; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Sleep Initiation and Maintenance Disorders

2000

Trials

24 trial(s) available for ribavirin and Depression

ArticleYear
RNA editing blood biomarkers for predicting mood alterations in HCV patients.
    Journal of neurovirology, 2019, Volume: 25, Issue:6

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Deaminase; Adult; Aged; Antiviral Agents; Biomarkers; Depression; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA Editing

2019
Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2014, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Anxiety; Data Interpretation, Statistical; Depression; Drug Therapy, Combination; Female; Health Status Indicators; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Patient Outcome Assessment; Placebos; Psychometrics; Quality of Life; Reproducibility of Results; Ribavirin; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult

2014
Measurement properties of the flu-like symptom index from the hepatitis physical symptom severity diary.
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2014, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Factor Analysis, Statistical; Fatigue; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Minnesota; Musculoskeletal Pain; Psychiatric Status Rating Scales; Reproducibility of Results; Ribavirin; Self Report; Severity of Illness Index; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome; Virginia; Young Adult

2014
Effects of escitalopram prophylaxis during antiviral treatment for chronic hepatitis C in patients with a history of intravenous drug use and depression.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:10

    Topics: Aged; Antiviral Agents; Citalopram; Comorbidity; Depression; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Placebos; Ribavirin; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Treatment Outcome; Young Adult

2014
Weight loss during telaprevir-based triple therapy due to telaprevir-induced appetite loss.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:22

    Topics: Antiviral Agents; Appetite; Body Weight; Depression; Drug Therapy, Combination; Female; Genotype; Ghrelin; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Ribavirin; Treatment Outcome; Weight Loss

2014
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 an
    Journal of viral hepatitis, 2015, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Aged; Anemia; Depression; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Fatigue; Female; Hepatitis C, Chronic; Humans; Incidence; Interferons; Liver; Male; Middle Aged; Placebos; Ribavirin; Simeprevir; Treatment Outcome; Viral Load; Young Adult

2015
Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.
    BMC psychiatry, 2016, Nov-15, Volume: 16, Issue:1

    Topics: Adult; Antioxidants; Antiviral Agents; Anxiety; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Psychiatric Status Rating Scales; Ribavirin; Silybin; Silymarin; Treatment Outcome; Work Performance

2016
Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
    BMC psychiatry, 2016, Nov-25, Volume: 16, Issue:1

    Topics: Antiviral Agents; Anxiety; China; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin

2016
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.
    Molecular psychiatry, 2010, Volume: 15, Issue:5

    Topics: Adrenocorticotropic Hormone; Adult; Antiviral Agents; Circadian Rhythm; Cytokines; Depression; Enzyme-Linked Immunosorbent Assay; Fatigue; Female; Hepatitis C; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Pituitary-Adrenal System; Ribavirin; Statistics as Topic; Statistics, Nonparametric

2010
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
    The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:2

    Topics: Antiviral Agents; Brain-Derived Neurotrophic Factor; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunologic Factors; Interferon-alpha; Male; Psychiatric Status Rating Scales; Ribavirin; Time Factors

2011
Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-α-2b and ribavirin.
    European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:12

    Topics: Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; Depression; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Self Report; Surveys and Questionnaires; Texas; Time Factors; Treatment Outcome; Veterans; Viral Load

2010
A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
    Journal of clinical gastroenterology, 2010, Volume: 44, Issue:9

    Topics: Antiviral Agents; Depression; Drug Monitoring; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Psychotherapy; Recombinant Proteins; Ribavirin; Severity of Illness Index

2010
Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue.
    Brain, behavior, and immunity, 2011, Volume: 25, Issue:6

    Topics: Antiviral Agents; Depression; Drug Therapy, Combination; Fatigue; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunity, Innate; Interferon alpha-2; Interferon-alpha; Interleukin-6; Lymphocytes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polyethylene Glycols; Protein Processing, Post-Translational; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors

2011
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:5

    Topics: Adult; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Drug Users; Employment; Female; Hepatitis C; HIV Seropositivity; Humans; Interferon-alpha; Logistic Models; Male; Mental Health; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Participation; Substance Abuse, Intravenous; Surveys and Questionnaires; Viral Load; Young Adult

2012
Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.
    Psychological medicine, 2012, Volume: 42, Issue:8

    Topics: 2',5'-Oligoadenylate Synthetase; Antiviral Agents; Computational Biology; Depression; Drug Therapy, Combination; Fatigue; Female; Gene Expression Profiling; Gene Expression Regulation; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocytes, Mononuclear; Longitudinal Studies; Male; Microarray Analysis; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; Severity of Illness Index

2012
Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.
    Journal of viral hepatitis, 2012, Volume: 19, Issue:11

    Topics: Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Treatment Outcome

2012
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.
    Journal of acquired immune deficiency syndromes (1999), 2004, Apr-15, Volume: 35, Issue:5

    Topics: Adult; Antiviral Agents; Depression; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome

2004
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
    Molecular psychiatry, 2005, Volume: 10, Issue:4

    Topics: Adult; Antiviral Agents; Anxiety; Depression; Drug Carriers; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance-Related Disorders; Time Factors; Treatment Outcome

2005
[Study of the efficacy of combined therapy with interferon alfacon-1 and ribavirin for chronic hepatitis C].
    Przeglad epidemiologiczny, 2006, Volume: 60, Issue:3

    Topics: Adult; Aged; Anemia; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin; Thyroiditis; Treatment Outcome; Viral Load

2006
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:6

    Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Viral Load

2007
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
    Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:4

    Topics: Adult; Antidepressive Agents; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Substance-Related Disorders; Treatment Outcome

2007
Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
    Alimentary pharmacology & therapeutics, 2008, Mar-01, Volume: 27, Issue:5

    Topics: Adult; Anemia; Antiviral Agents; Depression; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Viral Load

2008
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
    Contemporary clinical trials, 2008, Volume: 29, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Antiviral Agents; Canada; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Psychometrics; Recombinant Proteins; Ribavirin; Sample Size; Severity of Illness Index; Treatment Outcome

2008
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
    Molecular psychiatry, 2009, Volume: 14, Issue:12

    Topics: Adult; Antiviral Agents; Cohort Studies; Depression; Fatigue; Female; Gene Frequency; Genotype; Hepatitis C, Chronic; Humans; Interferon Type I; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Serotonin Plasma Membrane Transport Proteins

2009

Other Studies

55 other study(ies) available for ribavirin and Depression

ArticleYear
Depression Disorders in Patients with Chronic Hepatitis C.
    Psychiatria Danubina, 2020, Volume: 32, Issue:Suppl 4

    Topics: Antiviral Agents; Bosnia and Herzegovina; Buprenorphine; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Methadone; Ribavirin

2020
The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Journal of psychiatry & neuroscience : JPN, 2021, 01-18, Volume: 46, Issue:1

    Topics: Adult; Antiviral Agents; Cross-Sectional Studies; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Immunologic Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Longitudinal Studies; Male; Middle Aged; ortho-Aminobenzoates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tryptophan

2021
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
    Journal of affective disorders, 2021, 09-01, Volume: 292

    Topics: Antiviral Agents; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin

2021
Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea.
    Gut and liver, 2017, May-15, Volume: 11, Issue:3

    Topics: Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Prevalence; Prospective Studies; Psychiatric Status Rating Scales; Republic of Korea; Ribavirin; Sustained Virologic Response

2017
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin.
    BMC gastroenterology, 2017, Nov-25, Volume: 17, Issue:1

    Topics: Adult; Affect; Aged; Antiviral Agents; Attention; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Memory, Episodic; Middle Aged; Prospective Studies; Ribavirin; Sustained Virologic Response; Treatment Outcome

2017
Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation.
    International journal of psychiatry in medicine, 2018, Volume: 53, Issue:4

    Topics: Adult; Antiviral Agents; Depression; Diagnostic and Statistical Manual of Mental Disorders; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Ribavirin; Time Factors; Withholding Treatment

2018
Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study.
    European journal of clinical investigation, 2018, Volume: 48, Issue:12

    Topics: Actigraphy; Adult; Aged; Antiviral Agents; Depression; Exercise; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Pilot Projects; Ribavirin; Treatment Outcome; Tryptophan; Viral Load; Young Adult

2018
Getting more out of meta-analyses: a new approach to meta-analysis in light of unexplained heterogeneity.
    Journal of clinical epidemiology, 2019, Volume: 107

    Topics: Antidepressive Agents; Data Interpretation, Statistical; Depression; Hepatitis C; Humans; Hypericum; Meta-Analysis as Topic; Models, Statistical; Plant Extracts; Ribavirin; Treatment Outcome

2019
Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2019, Volume: 28, Issue:9

    Topics: Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Prospective Studies; Psychiatric Status Rating Scales; Ribavirin

2019
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study.
    International journal of psychiatry in medicine, 2019, Volume: 54, Issue:6

    Topics: Adult; Antiviral Agents; Anxiety; Cognition; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Polyethylene Glycols; Prospective Studies; Ribavirin

2019
Perspectives of a self-selected sample of former patients on the long-term health outcomes of interferon-based hepatitis C treatments: an exploratory study.
    Psychology, health & medicine, 2013, Volume: 18, Issue:6

    Topics: Adult; Aftercare; Anorexia; Antiviral Agents; Attitude of Health Personnel; Chronic Disease; Cognition Disorders; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neurotoxicity Syndromes; New South Wales; Patient Education as Topic; Qualitative Research; Quality of Life; Recurrence; Ribavirin; Sarcoidosis; Self Report; Severity of Illness Index; Treatment Outcome; Victoria

2013
Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
    Psychoneuroendocrinology, 2013, Volume: 38, Issue:9

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Cohort Studies; Depression; Drug Therapy, Combination; Fatigue; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; INDEL Mutation; Interferon-alpha; Interleukin-6; Middle Aged; Point Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Prospective Studies; Recombinant Proteins; Ribavirin; Serotonin; Serotonin Plasma Membrane Transport Proteins; White People

2013
The importance of a prior psychiatric examination in pegylated interferon and ribavirin combination treatment for chronic hepatitis C.
    The Kurume medical journal, 2012, Volume: 59, Issue:3-4

    Topics: Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome

2012
Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy.
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Biomarkers; Cytokines; Depression; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Inflammation Mediators; Interferons; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Ribavirin; RNA, Viral; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Viral Load

2014
Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.
    Journal of clinical gastroenterology, 2015, Volume: 49, Issue:1

    Topics: Antiviral Agents; Communication; Depression; Educational Status; Female; Hepatitis C, Chronic; Humans; Insurance, Health; Interferons; Interpersonal Relations; Male; Medication Adherence; Physician-Patient Relations; Polyethylene Glycols; Proportional Hazards Models; Prospective Studies; Ribavirin; Self Efficacy

2015
Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
    Psychosomatic medicine, 2014, Volume: 76, Issue:3

    Topics: Adult; Analysis of Variance; Antiviral Agents; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Depression; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Nitric Oxide Synthase; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Ribavirin; Risk Factors; Time Factors

2014
Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:6

    Topics: Adult; Antiviral Agents; Depression; Disease Progression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Mental Disorders; Middle Aged; Multivariate Analysis; Ribavirin; Schizophrenia

2014
Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Journal of psychosomatic research, 2014, Volume: 77, Issue:2

    Topics: Adult; Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Personality Inventory; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Severity of Illness Index

2014
Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment.
    Journal of neurovirology, 2014, Volume: 20, Issue:6

    Topics: Adult; Affect; Antiviral Agents; Cognition; Depression; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Psychological Tests; Recombinant Proteins; Ribavirin; Viral Load

2014
Self-reported need for psychotherapy predicts interferon-induced depression in hepatitis C: stratification for interferon-free treatment.
    Antiviral therapy, 2015, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Psychotherapy; Recombinant Proteins; Ribavirin; Self Report; Surveys and Questionnaires; Young Adult

2015
[Natural human IFNβ and ribavirin combination therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:2

    Topics: Aged; Depression; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-beta; Ribavirin; Thrombocytopenia

2015
Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
    Journal of psychosomatic research, 2015, Volume: 79, Issue:6

    Topics: Adult; Aged; Antidepressive Agents; Antiviral Agents; Depression; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Ribavirin

2015
Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
    Physiology & behavior, 2016, Nov-01, Volume: 166

    Topics: Adrenocorticotropic Hormone; Adult; Antiviral Agents; Area Under Curve; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Fatigue; Female; Glucocorticoids; Hepatitis C; Humans; Hydrocortisone; Inflammation; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Receptors, Tumor Necrosis Factor, Type II; Ribavirin; Tumor Necrosis Factor-alpha

2016
Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.
    The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:4

    Topics: Adult; Antiviral Agents; Brain-Derived Neurotrophic Factor; Catechol O-Methyltransferase; Depression; Female; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; Incidence; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; Ribavirin; Tacrolimus Binding Proteins; Treatment Outcome; White People

2016
Functional Polymorphism in the Interleukin 6 (IL6) Gene with Respect to Depression Induced in the Course of Interferon-α and Ribavirin Treatment in Chronic Hepatitis Patients.
    Archivum immunologiae et therapiae experimentalis, 2016, Volume: 64, Issue:Suppl 1

    Topics: Adult; Antiviral Agents; Cohort Studies; Depression; Female; Genetic Predisposition to Disease; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Poland; Polyethylene Glycols; Polymorphism, Genetic; Prevalence; Recombinant Proteins; Ribavirin

2016
"Look, I'm fit, I'm positive and I'll be all right, thank you very much": coping with hepatitis C treatment and unrealistic optimism.
    Psychology, health & medicine, 2008, Volume: 13, Issue:3

    Topics: Adaptation, Psychological; Adjustment Disorders; Adult; Antiviral Agents; Attitude of Health Personnel; Culture; Decision Making; Denial, Psychological; Depression; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interview, Psychological; Male; Middle Aged; New South Wales; Patient Acceptance of Health Care; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sick Role

2008
Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.
    The American journal of gastroenterology, 2008, Volume: 103, Issue:11

    Topics: Affect; Antiviral Agents; Biomarkers; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2008
Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy.
    Clinical and investigative medicine. Medecine clinique et experimentale, 2009, Jun-01, Volume: 32, Issue:3

    Topics: Adult; Antiviral Agents; Cohort Studies; Cytokines; Depression; Female; Hepatitis C, Chronic; Humans; Interleukin-10; Interleukin-2; Interleukin-4; Interleukin-6; Male; Middle Aged; Quality of Life; Ribavirin; Tumor Necrosis Factor-alpha

2009
Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection.
    Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:7

    Topics: Adult; Antidepressive Agents; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Drug Users; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Mental Disorders; Middle Aged; Odds Ratio; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; RNA, Viral; Substance Abuse, Intravenous; Treatment Failure; Viral Load

2009
Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:12

    Topics: Antiviral Agents; Chi-Square Distribution; Cross-Sectional Studies; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Multicenter Studies as Topic; Prevalence; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; United States

2009
Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
    Journal of hepatology, 2010, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Blood Platelets; Citalopram; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors; Young Adult

2010
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.
    Molecular psychiatry, 2010, Volume: 15, Issue:4

    Topics: Adult; Antiviral Agents; Chemokine CCL2; Chromatography, High Pressure Liquid; Cytokines; Depression; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis C; Humans; Interferon-alpha; Kynurenine; Longitudinal Studies; Male; Middle Aged; Quinolinic Acid; Receptors, Tumor Necrosis Factor, Type II; Ribavirin; Statistics as Topic; Tryptophan

2010
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
    Journal of substance abuse treatment, 2010, Volume: 38, Issue:4

    Topics: Adult; Antidepressive Agents; Antiviral Agents; Buprenorphine; Citalopram; Depression; Directly Observed Therapy; Drug Administration Schedule; Female; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome; Young Adult

2010
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Pharmacological research, 2011, Volume: 63, Issue:1

    Topics: Adult; Antiviral Agents; Case-Control Studies; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon alpha-2; Interferon-alpha; Italy; Kynurenine; Male; Middle Aged; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Serotonin; Time Factors; Treatment Outcome; Tryptophan

2011
[Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    Gastroenterologia y hepatologia, 2011, Volume: 34, Issue:4

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Incidence; Interferon-alpha; Retrospective Studies; Ribavirin

2011
Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Brain, behavior, and immunity, 2011, Volume: 25, Issue:7

    Topics: Adult; Alleles; Antiviral Agents; Brazil; Cross-Sectional Studies; Depression; Depressive Disorder; Female; Genetic Association Studies; Genotype; Hepatitis C; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Ribavirin

2011
Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Addiction (Abingdon, England), 2012, Volume: 107, Issue:1

    Topics: Adult; Anti-Retroviral Agents; Antiviral Agents; Coinfection; Depression; Drug Therapy, Combination; Ethanol; Female; France; Health Services Accessibility; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Medication Adherence; Middle Aged; Prospective Studies; Ribavirin; Socioeconomic Factors; Substance Abuse, Intravenous; Surveys and Questionnaires

2012
Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:19

    Topics: Aged; Antiviral Agents; Cohort Studies; Depression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferon-beta; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Treatment Outcome

2011
Retrospective chart review to assess the relationship between depression and sustained virological response from interferon treatment for hepatitis C virus.
    Clinical therapeutics, 2011, Volume: 33, Issue:10

    Topics: Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Logistic Models; Male; Medical Records; Multivariate Analysis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load

2011
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2

    Topics: Adult; Alcohol Drinking; Antidepressive Agents; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Medical Records; Mental Disorders; Methadone; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Ribavirin; Risk Factors; Substance-Related Disorders

2003
Assessment of depression in patients with chronic hepatitis: effect of interferon treatment.
    Digestive diseases (Basel, Switzerland), 2002, Volume: 20, Issue:3-4

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Depression; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin; Surveys and Questionnaires

2002
Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy.
    Pharmacotherapy, 2004, Volume: 24, Issue:11

    Topics: Adult; Aged; Antiviral Agents; Cardiovascular Diseases; Depression; Female; Follow-Up Studies; France; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin

2004
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
    Antiviral therapy, 2004, Volume: 9, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Ribavirin

2004
Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
    Journal of viral hepatitis, 2005, Volume: 12, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Ribavirin; Selective Serotonin Reuptake Inhibitors

2005
Interferon-induced depression: prevalence and management.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Depression; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Prevalence; Prognosis; Review Literature as Topic; Ribavirin; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2005
[Neuropsychiatric disorders in HCV-infected people--own observations].
    Przeglad epidemiologiczny, 2005, Volume: 59, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Poland; Psychiatric Status Rating Scales; Quality of Life; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors; Treatment Outcome

2005
Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2006, Volume: 38, Issue:2

    Topics: Adult; Antiviral Agents; Comorbidity; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Substance Abuse, Intravenous

2006
Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report.
    The AIDS reader, 2005, Volume: 15, Issue:11

    Topics: Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Treatment Outcome

2005
Depression, anemia and health-related quality of life in chronic hepatitis C.
    Journal of hepatology, 2006, Volume: 44, Issue:3

    Topics: Adult; Aged; Anemia; Antiviral Agents; Depression; Female; Follow-Up Studies; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prognosis; Prospective Studies; Quality of Life; Recombinant Proteins; Ribavirin; Risk Factors; Surveys and Questionnaires

2006
Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells.
    Scandinavian journal of immunology, 2006, Volume: 63, Issue:2

    Topics: Antiviral Agents; Blotting, Western; Depression; Gene Expression Regulation; Hepatitis; Humans; Interferon-alpha; Jurkat Cells; Lamivudine; Leukocytes, Mononuclear; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Serotonin; Serotonin Plasma Membrane Transport Proteins; T-Lymphocytes; U937 Cells

2006
Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2007, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Antiviral Agents; Blood Coagulation Disorders; Combined Modality Therapy; Depression; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load

2007
Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:10

    Topics: Adolescent; Adult; Antidepressive Agents; Antiviral Agents; Citalopram; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Pilot Projects; Quality of Life; Ribavirin; Secondary Prevention; Severity of Illness Index; Treatment Outcome

2007
Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?
    Chemotherapy, 2007, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007
De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C.
    Alimentary pharmacology & therapeutics, 2008, Feb-01, Volume: 27, Issue:3

    Topics: Adult; Antiviral Agents; Anxiety Disorders; Chi-Square Distribution; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Educational Status; Emigrants and Immigrants; Employment; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Treatment Outcome

2008
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C.
    Brain, behavior, and immunity, 2008, Volume: 22, Issue:6

    Topics: Adult; Antiviral Agents; Basal Ganglia; Depression; Fatigue; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychiatric Status Rating Scales; Reaction Time; Regression Analysis; Ribavirin

2008